Abstract
Progesterone acts as an important factor in maintenance of pregnancy and development of equine embryo. Treatment with letrozole, a nonsteroidal inhibitor of aromatase enzyme regulating the synthesis of estrogens, during the preovulatory period has been reported to result in larger corpus lutea (CLs) with greater progesterone production in human and bovine. The present study was conducted to evaluate the effect of preovulatory administration of letrozole on the size of CL and progesterone concentration. In the present study, mares (n = 7) received PGF2α (250 μg) 14 days after the observed ovulation and were subjected to daily ultrasonography to evaluate the development of the largest follicle and the resultant CL for two consecutive estrous cycles. In addition, progesterone concentration was measured over the course of luteal phases. During the first cycles, as control cycles, mares received no treatment. During the second cycles, mares received letrozole (0.5 mg/kg) orally beginning from PGF2α administration for 3 days. Letrozole reduced the diameter of ovulatory follicle (P < 0.05) and advanced the time of ovulation (P < 0.05). There was also a tendency for formation of smaller CLs following letrozole administration (P = 0.065). Moreover, concentration of progesterone during midluteal phase was lower following letrozole treatment (P < 0.05). In conclusion, the present study showed that letrozole treatment during the preovulatory period could result in premature ovulation and impair the function of subsequent CL.
Similar content being viewed by others
References
Allen WR (2001) Luteal deficiency and embryo mortality in the mare. Reprod Domest Anim 36:121–131
Bedaiwy MA, Abdelaleem MA, Hussein M, Mousa N, Brunengraber LN, Casper RF (2011) Hormonal, follicular and endometrial dynamics in letrozole-treated versus natural cycles in patients undergoing controlled ovarian stimulation. Reprod Biol Endocrinol 9:83. doi:10.1186/1477-7827-9-83
Bhatnagar A (2007) The discovery and mechanism of action of letrozole. Breast Cancer Res Treat 105:7–17. doi:10.1007/s10549-007-9696-3
Checura CM, Beg MA, Parrish JJ, Ginther OJ (2010) Positive effect of FSH but not LH on early development of the dominant follicle in mares. Reprod Fertil Dev 22:1092–1099. doi:10.1071/RD09275
Cohen MH, Johnson JR, Li N, Chen G, Pazdur R (2002) Approval summary: letrozole in the treatment of postmenopausal women with advanced breast cancer. Clin Cancer Res 8:665–669
Ginther OJ, Beg MA, Gastal MO, Gastal EL (2004) Follicle dynamics and selection in mares. Anim Reprod 1:45–63
Kastelic JP, Adams GP, Ginther OJ (1987) Role of progesterone in mobility, fixation, orientation, and survival of the equine embryonic vesicle. Theriogenology 27:655–663
Mitwally MF, Casper RF (2001) Use of aromatase inhibitor for induction of ovulation in patients with an inadequate response to clomiphene citrate. Fertil Steril 75:305–309
Pycock JF, Newcombe JR (1996) The effect of the gonadotrophin-releasing hormone analog, buserelin, administered in diestrus on pregnancy rates and pregnancy failure in mares. Theriogenology 6:1097–1101
Requena A, Herrero J, Landeras J, Navarro E, Neyro JL, Salvador C, Tur R, Callejo J, Checa MA, Farré M, Espinós JJ, Fábregues F, Granã-Barcia M (2008) Use of letrozole in assisted reproduction: a systematic review and meta-analysis. Hum Reprod Update 14:571–582. doi:10.1093/humupd/dmn033
Schauer SN, Guillaume D, Decourt C, Watson ED, Briant C, Donadeu FX (2013) Effect of luteinizing hormone overstimulation on equine follicle maturation. Theriogenology 79:409–416. doi:10.1016/j.theriogenology.2012.08.017
Squires EL, McCue PM (2007) Superovulation in mares. Anim Reprod Sci 99:1–8. doi:10.1016/j.anireprosci.2006.04.054
Statistical Analysis Systems Institute (2008) User’s guide version 9.2: statistics. SAS Institute, Cary NC, USA
Stein T, Ball B, Conley A, Bhatnagar A, Roser J (2002) The effects of an aromatase inhibitor (letrozole) on hormone and sperm production in the stallion. Theriogenology 58:381–383. doi:10.1016/S0093-691X(02)00873-7
Usluogullari B, Duvan C, Usluogullari C (2015) Use of aromatase inhibitors in practice of gynecology. J Ovarian Res 8:4. doi:10.1186/s13048-015-0131-9
Yapura J, Mapletoft RJ, Pierson R, Singh J, Naile J, Giesy JP, Adams GP (2011) A bovine model for examining the effects of an aromatase inhibitor on ovarian function in women. Fertil Steril 96:434–438. doi:10.1016/j.fertnstert.2011.05.038
Yapura MJ, Mapletoft RJ, Singh J, Pierson R, Naile J, Giesy JP, Chang H, Higley E, Hecker M, Adams GP (2012) Effects of a non-steroidal aromatase inhibitor on ovarian function in cattle. Reprod Fertil Dev 24:631–640. doi:10.1071/RD11239
Yapura J, Mapletoft RJ, Pierson RA, Singh J, Adams GP (2013) Aromatase inhibitor treatment with an intravaginal device and its effect on pre-ovulatory ovarian follicles in a bovine model. Reprod Biol Endocrinol 11:97. doi:10.1186/1477-7827-11-97
Yapura MJ, Mapletoft RJ, Pierson RA, Singh J, Adams GP (2014) Effect of vehicle and route of administration of letrozole on ovarian function in a bovine model. Reprod Fertil Dev 26:1198–1205. doi:10.1071/RD13100
Acknowledgements
The authors would like to thank the staff at Veterinary Research and Teaching Hospital, University of Tehran, for their kind assistance.
Authors’ contribution
VA performed the experiments and statistical analyses and wrote the manuscript. VA and FG participated in the study design and revised the manuscript. AM participated in the implementation of experiments. All authors read and approved the final manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
All applicable international, national, and/or institutional guidelines for the care and use of animals were followed.
Conflict of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Akbarinejad, V., Gharagozlou, F. & Mansourizadeh, A. The effects of preovulatory administration of oral letrozole on ovulatory follicle and the subsequent corpus luteum in mares. Comp Clin Pathol 26, 359–362 (2017). https://doi.org/10.1007/s00580-016-2381-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00580-016-2381-3